Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6

Molecular Carcinogenesis

Volumn 15, Issue 4, 1996, Pages 284-299

  Miele, Mary E ^a,d   Robertson, Gavin ^b   Lee, Jeong Hyung ^a   Coleman, Aaron ^b   McGary, Carl T ^a,e   Fisher, Paul B ^c   Lugo, Tracy G ^b   Welch, Danny R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Athymic nude mouse; CIP1; Metastasis suppressor gene; Microcell mediated chromosome transfer; Sdi1; WAF1

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CARCINOGENICITY; CHROMOSOME 1; CHROMOSOME 6; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 6; DNA PRIMERS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; HYBRID CELLS; MELANOMA; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029867951     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G     Document Type: Article

References (77)

1. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 19-20:219-240, 1994.
2. Koh HK Cutaneous melanoma. N Engl J Med 325:171-182, 1991.
3. Frost P, Levin B. Clinical implications of metastatic process. Lancet 339:1458-1461, 1992.
4. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 319:525-532, 1990.
5. Liotta LA. Cancer cell invasion and metastasis. Sci Am 266:54-63, 1992.
6. Dear TN, Kefford RF. Molecular oncogenetics of metastasis. Mol Aspects Med 11:243-324, 1990.
7. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336, 1991.
8. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 51:5054s-5059s, 1991.
9. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP. Evidence for a novel gene associated with low tumor metastatic potential, J Natl Cancer Inst 80:200-204, 1988.
10. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49 5185-5190, 1989
11. Radinsky R, Weisberg HZ, Staroselsky AN, Fidler IJ. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res 52:5808-5814, 1992.
12. Ichikawa T, Ichikawa Y, Dong J, et al. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 52:3486-3490, 1992.
13. Dong J-T, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884-886, 1995.
14. Welch DR, Chen P, Miele ME, et al. Microcell-mediated transfer of chromosome 6 into metastatic human CS161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9:255-262, 1994.
15. Dracopoli NC, Harnett PR, Bale SJ, et al. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma turnor progression. Proc Natl Acad Sci USA 86.4614-4618, 1989.
16. Fountain JW, Bale SJ, Housman DE, Dracopoli NC. Genetics of melanoma Cancer Surv 9:645-671, 1990.
17. Trent JM. Cytogenetics of human malignant melanoma. Cancer Metastasis Rev 10 103-113, 1991.
18. Parmiter AH, Nowell PC The cytogenetics of human malignant melanoma and premalignant lesions In: Nathanson L. Malignant Melanoma. Biology, Diagnosis and Therapy Kluwer Academic Publishers, Boston, 1988, pp 43-61.
19. Dracopoli NC, Bale SJ. Genetic aspects of cutaneous malignant melanoma. Semin Oncol 15:541-548, 1988.
20. Dracopoli NC, Sam B, Fountain JW, Schartl M. A homolog of the Xiphophorus melanoma-inducing locus Xmrk maps to 6q27 a region frequently involved in rearrangements and deletions in human melanomas. Abstract Am J Hum Genet 54:A51, 1992.
21. Kacker RK, Giovanella BC, Pathak S. Consistent karyotypic abnormalities in human malignant melanomas. Anticancer Res 10:859-872, 1990.
22. Guan X, Meltzer PS, Cao J, Trent JM. Rapid generation of region-specific genomic clones by chromosome microdissection Isolation of DNA from a region frequently deleted in malignant melanoma Genomics 14 680-684, 1992
23. Pathak S, Drwinga HL, Hsu TC. Involvement of chromosome 6 in rearrangements in human malignant melanoma. Cancer Genet Cytogenet 36:573-579, 1983.
24. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440, 1994.
25. Parker C, Lakshmi MS, Piura B, Sherbet GV. Metastasis-associated mis1 gene expression correlates with increased p53 detection in the B16 murine melanoma. DNA Cell Biol 13:343-351, 1994.
26. Skolnick MH, Cannon-Albright LA, Kamb A. Genetic predisposition to melanoma. Eur J Cancer [A] 30.1991-1995, 1994.
27. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma Nat Genet 8:15-21, 1994.
28. Cowan JM, Halaban R, Francke U Cytogenetic analysis of meianocytes from premalignant nevi and melanomas. J Natl Cancer Inst 80:1159-1164, 1988.
29. Trent JM, Stanbridge EJ, McBride HL, et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247 568-571, 1990
30. Robertson GR, Coleman AC, Kanakaraj K, Ramos J, Stanbridge EJ, Lugo TG. Reintroduction of chromosomes 1, 6 and 9 into human malignant melanoma cells. Abstract. Proceedings of the American Association for Cancer Research 35:1119, 1994.
31. Church SL, Grant JW, Meese EU, Trent JM. Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/ SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics 14:823-825, 1992.
32. Church SL, Grant JW, Ridnour LA, et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 90:3113-3117, 1993.
33. Bravard A, Sabatier L, Hoffschir F, Ricoul M, Luccioni C, Dutrillaux B. SOD2: A new type of tumor suppressor gene? Int J Cancer 51:476-480, 1992
34. Miele ME, Welch DR Transfection of SOD2 into a highly metastatic human melanoma cell line C8161 does not alter tumorigenicity or metastatic ability Abstract Proceedings of the American Association for Cancer Research 36:455, 1995.
35. Johnson JP, Demmer-Dieckmann M, Meo T, Hadam MR, Reithmuller G. Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin. Eur J Immunol 11.825-831, 1981.
36. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ. Dissociation of suppression of tumongenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2:246-255, 1991
37. Lugo TG, Handelin B, Killary AM, Housman DE, Fournier REK. Isolation of microcell hybrid clones containing retroviral vector insertions into specific chromosomes. Mol Cell Biol 7:2814-2820, 1987.
38. Fournier REK, Ruddle FH Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci USA 74:319-323, 1991
39. Sanford JA, Stubblefield E. General protocol for microcell-mediated chromosome transfer. Somat Cell Mol Genet 13:279-284, 1987.
40. Stubblefield E, Pershouse M, Direct formation of microcells from mitotic cells for use in chromosome transfer. Somat Cell Mol Genet 18:485-491, 1992.
41. Miller AD, Rosman GJ. Improved retroviral vector for gene transfer and expression. Biotechniques 7 980-990, 1989.
42. Barch MJ. ACT Cytogenetics Laboratory Manual. Raven Press, New York, 1991.
43. Trask B, Pinkel D Fluorescence in situ hybridization with DNA probes Methods Cell Biol 33 383-400, 1990
44. Trask BJ, Pinkel D Fluorescence in situ hybridization with DNA probes. In Crissman HA, Darzynkiewicz Z. Flow Cytometry, Vol 33. Academic Press, New York, 1990, pp 383-400
45. Hogg N, Allen C, Edgeworth J. Monoclonal antibody 5.5 reacts with p8.14, a myeloid molecule associated with some vascular endothelium. Eur J Immunol 19 1053-1061, 1989.
46. Cooke HJ, Hindley J Cloning of human satellite 111 DNA: Different components are on different chromosomes Nucleic Acids Res 6:3177-3197, 1979
47. Ausubel FM, Brent R, Kingston RE, et al. Current Protocols in Molecular Biology. Greene Publishing and John Wiley & Sons, New York, 1990.
48. Jiang H, Lin J, Su Z, et al The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells Oncogene 10 1855-1864, 1995.
49. Welch DR, BISI JE, Miller BE, et al. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line, Int J Cancer 47 227-237, 1991.
50. Welch DR, Meri A, Nicolson GL. Comparison of 'spontaneous' and 'experimental' metastasis using rat 13752 mammary adenocarcinoma cell clones Invasion Metastasis 3 65-80, 1983
51. Eastmond DA, Pinkel D. Detection of aneuploidy and aneuploidyinducing agents in human lymphocytes using fluorescence in situ hybridization with specific DNA probes. Mutat Res 234 303-318, 1990
52. Jiang H, Lin J, Fisher PB A molecular definition of terminal cell differentiation in human melanoma cells Mol Cell Differ 2:221-239, 1994.
53. Hoizmann B, Brocker EB, Lehmann JM, et al Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes. Int J Cancer 39.466-471, 1987.
54. Albelda SM, Mette SA, Elder DE, et al. Integrin distribution in malignant melanoma Association of the beta-3 subunit with tumor progression Cancer Res 50.6757-6764, 1990
55. Dracopoli N, Bruns G. Report of the First International Workshop on Human Chromosome 1 Mapping 1994, held on March 25-27, 1994, at Bethesda MD (USA). Cytogenet Cell Genet 67:143-174, 1994.
56. Bruns GA, Dracopoli NC Report of the committee on the genetic constitution of chromosome 1. Cancer Genet Cytogenet 58:103-141, 1992
57. Prenger VL, Colyer CR, Mellen SG, Harris EL, Beaty TH, Meyers DA. Estimated power to detect linkage in three CM/ON data sets Cancer Genet Cytogenet 59:220-222, 1992.
58. Blossey H, Guo SW, McKnight B, Tierney C, Thompson E, Wijsman E Linkage analysis of malignant melanoma with the chromosome 1 markers and PND Cancer Genet Cytogenet 59:182-184, 1992.
59. Klein KG, Bouck NP. The distal region of the long arm of human chromosome 1 carries tumor suppressor activity for a human fibrosarcoma line. Cancer Genet Cytogenet 73.109-121, 1994.
60. Miyamoto S, Nishida M, Miwa K, et al. Increased actin cable organization after single chromosome introduction. Association with suppression of in vitro cell growth rather than tumorigenic suppression. Mol Carcinog 10:88-96, 1994
61. Sugawara O, Oshimura M, Koi M, Annab LA, Barrett JC. Induction of cellular senescence in immortalized cells by human chromosome 1. Science 247:707-710, 1990.
62. You J, Miele ME, Dong C, Welch DR. Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion Biochem Biophys Res Commun 208 476-484, 1995
63. Fisher PB, Prignoti DR, Hermo H, Weinstein IB, Pestka S. Effects of combined treatment with Interferon and mezerein on melanogenesis and growth of human melanoma cells J Interferon Res 5.11-22, 1985.
64. Jiang H, Su Z-Z, Boyd J, Fisher PB. Gene expression changes associated with reversible growth suppression and the induction of terminal differentiation in human melanoma cells. Mol Cell Differ 1:41-66, 1993
65. Jiang H, Fisher PB Use of a highly sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol Cell Differ 1:285-299, 1993.
66. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21 (WAF1/CIP1) expression in the absence of p53. Oncogene 9.3397-3406, 1994
67. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA. El-Houseini ME. Induction of p21 (WAF1/CIP1) during differentiation Oncogene 9:3397-3406, 1994.
68. Bhatia K, Fan S, Spangler G, et al. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. Cancer Res 55:1431-1435, 1995.
69. klp1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell 78 59-66, 1994.
70. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662, 1995.
71. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K. Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368.753-756, 1994.
72. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 55.1436-1440, 1995
73. Liu Q, Neuhausen S, McClure M, et al. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10:1061-1067, 1995.
74. Tremblay KD, Saam JR, Ingram RS, Tilghman SM, Bartolomei MS. A paternal-specific methylation imprint marks the alleles of the mouse H19 gene. Nat Genet 9:407-413, 1995.
75. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10:1193-1198, 1995
76. Volz A, Boyle JM, Cann HM, Cottingham RW, Orr HT, Ziegler A. Report of the Second International Workshop on Human Chromosome 6. Genomics 21.464-472, 1994
77. Rieber MS, Welch DR, Miele ME, Raber M. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridinemediated growth arrest of human melanoma cells Cell Growth Differ 7.197-202, 1996.